PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) EBIT : Rp Mil (TTM As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is PT Diagnos Laboratorium Utama Tbk EBIT?

PT Diagnos Laboratorium Utama Tbk's earnings before interest and taxes (EBIT) for the six months ended in . 20 was Rp0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

PT Diagnos Laboratorium Utama Tbk EBIT Historical Data

The historical data trend for PT Diagnos Laboratorium Utama Tbk's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Diagnos Laboratorium Utama Tbk EBIT Chart

PT Diagnos Laboratorium Utama Tbk Annual Data

Trend

EBIT

PT Diagnos Laboratorium Utama Tbk Semi-Annual Data

EBIT

Competitive Comparison of PT Diagnos Laboratorium Utama Tbk's EBIT

For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Diagnos Laboratorium Utama Tbk's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's EV-to-EBIT falls into.

PT Diagnos Laboratorium Utama Tbk EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was Rp Mil.

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

PT Diagnos Laboratorium Utama Tbk's annualized ROC % for the quarter that ended in . 20 is calculated as:

	ROC % (Q: . 20 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: . 20 )	+	Invested Capital (Q: . 20 ))	/ count )
=	* ( 1 - % )	/	( (	+	)	/ )
=		/
=	%

where

Invested Capital

(Q: . 20 )

Total Assets

Accounts Payable & Accrued Expense

Excess Cash

Total Assets

Accounts Payable & Accrued Expense

( Cash, Cash Equivalents, Marketable Securities

max(0, Total Current Liabilities

Total Current Assets

Cash, Cash Equivalents, Marketable Securities

))

(

max(0,

))

Invested Capital

(Q: . 20 )

Total Assets

Accounts Payable & Accrued Expense

Excess Cash

Total Assets

Accounts Payable & Accrued Expense

( Cash, Cash Equivalents, Marketable Securities

max(0, Total Current Liabilities

Total Current Assets

Cash, Cash Equivalents, Marketable Securities

))

(

max(0,

))

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

PT Diagnos Laboratorium Utama Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

	ROC (Joel Greenblatt) %		(Q: . 20 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: . 20		Q: . 20
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=		/	( ( ( + max(, 0))	+	( + max(, 0)) )	/	)
=		/	( (	+	)	/	)
=		/
=	%

where Working Capital is:

	Working Capital		(Q: . 20 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(	+		+	)	-	(	+		+	)
=

	Working Capital		(Q: . 20 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(	+		+	)	-	(	+		+	)
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

PT Diagnos Laboratorium Utama Tbk's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: . 20 )
	=		/	322500.000
	=	%

PT Diagnos Laboratorium Utama Tbk EBIT Related Terms

Thank you for viewing the detailed overview of PT Diagnos Laboratorium Utama Tbk's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Teuku Cik Ditiro 1 No. 11 A, B, C, Gedung Graha Anam, 2nd Floor, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350

Website

https://www.diagnos.co.id

PT Main Laboratory Diagnos Tbk provides laboratory services that includes health support service activities that are managed by both the government and the private sector, such as health laboratories. The company's products and services include Service Home Service, Corporate Service, Clinical Laboratory, Genomics Laboratory, Inspection Package, Homecare Diagnos, and Examination Panel.